FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Amneal Pharmaceuticals chlorproMAZINE Hydrochloride Tablets Recall

chlorproMAZINE Hydrochloride Tablets, USP, 100 mg, 100-count bottle, Rx Only, Manufact…

Amneal Pharmaceuticals, LLC · Bridgewater, NJ

Risk level
Class II
Reported by FDA
Sep 10, 2025
Recall ID
D-0618-2025
Check your lot numberHow we source this data

Summary

Amneal Pharmaceuticals recalled chlorproMAZINE Hydrochloride Tablets starting Aug 18, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0618-2025 on Sep 10, 2025. Reason: Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets. Status: Ongoing.

Why it was recalled

Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

Product description

chlorproMAZINE Hydrochloride Tablets, USP, 100 mg, 100-count bottle, Rx Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213, INDIA; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 69238-1060-1.

Lot numbers, UPCs & expiration codes

Lot: AM240334, AM240335, Exp Date 02/28/2027, AM241031, Exp Date 06/30/2027.

Where it was sold

Distributed Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0618-2025
Classification
Class II
Status
Ongoing
Recall initiated
Aug 18, 2025
FDA report date
Sep 10, 2025
Quantity
14,923 100-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Amneal Pharmaceuticals, LLC

Original FDA data

Every field from FDA enforcement report D-0618-2025, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Ongoing
Country
United States
Event ID
97438
Address
400 Crossing Blvd Fl 3
Code information
Lot: AM240334, AM240335, Exp Date 02/28/2027, AM241031, Exp Date 06/30/2027.
Postal code
08807-2863
Report date
Sep 10, 2025
Product type
Drugs
Recall number
D-0618-2025
Classification
Class II
Recalling firm
Amneal Pharmaceuticals, LLC
Product quantity
14,923 100-count bottles
Reason for recall
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
chlorproMAZINE Hydrochloride Tablets, USP, 100 mg, 100-count bottle, Rx Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213, INDIA; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 69238-1060-1.
Distribution pattern
Distributed Nationwide in the USA
Recall initiation date
Aug 18, 2025
Initial firm notification
Letter
Center classification date
Sep 4, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0618-2025, published Sep 10, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls